Meeting Report

CAR T-Cell Therapy: On the Verge of Breakthrough in Many Hematologic Malignancies

Presented by Edward Stadtmauer, MD, and Patricia A. Mangan, RN, MSN, APRN-BC

University of Pennsylvania Abramson Cancer Center, Philadelphia


J Adv Pract Oncol 2017;8:228–231 | https://doi.org/10.6004/jadpro.2017.8.3.3 | © 2017 Harborside Press®


  

ABSTRACT

There have been promising results from clinical trials on the efficacy of engineering patients' immune cells to treat their cancers. CAR T-cell therapy also has unique toxicities advanced practitioners should be aware of.




For access to the full length article, please sign in.

Section Seperator
ADVERTISEMENT
Section Seperator
ADVERTISEMENT
Section Seperator
ADVERTISEMENT
Section Seperator
Copyright © 2016 Harborside Press, LLC All rights reserved.                Home | Current Issue | Previous Issue | Submissions | About JADPRO | Advertising | Privacy Policy | Contact
Copyright Notice/Disclaimer
Bot trap - Don't go here